Oral Antibiotic Treatment for Uncomplicated Cellulitis
For uncomplicated cellulitis, prescribe a beta-lactam antibiotic (cephalexin 500 mg four times daily, dicloxacillin 250-500 mg every 6 hours, or amoxicillin) for exactly 5 days if clinical improvement occurs—MRSA coverage is unnecessary in typical cases. 1, 2
First-Line Oral Antibiotic Selection
Beta-lactam monotherapy is the standard of care, achieving 96% success rates in typical nonpurulent cellulitis because the primary pathogens are beta-hemolytic streptococci and methicillin-sensitive Staphylococcus aureus. 1, 3
Recommended oral agents include:
- Cephalexin 500 mg orally every 6 hours (four times daily) 1, 2
- Dicloxacillin 250-500 mg every 6 hours 1, 2
- Amoxicillin (standard dosing) 1, 2
- Penicillin V 250-500 mg four times daily 1
- Amoxicillin-clavulanate 875/125 mg twice daily (particularly for bite-associated cellulitis) 1
For penicillin allergy:
- Clindamycin 300-450 mg every 6 hours provides coverage for both streptococci and MRSA, avoiding the need for combination therapy 1, 2
- Levofloxacin 500 mg daily can be used but should be reserved for beta-lactam allergies 1, 2
Treatment Duration: The 5-Day Rule
Treat for exactly 5 days if clinical improvement has occurred; extend only if symptoms have not improved within this timeframe. 1, 2 This recommendation is supported by high-quality randomized controlled trial evidence showing 5-day courses are as effective as 10-day courses. 4, 5
Clinical improvement criteria at day 5:
- Warmth and tenderness have resolved 1
- Erythema is improving (not necessarily completely resolved) 1
- Patient is afebrile 2
Common pitfall: Do not reflexively extend treatment to 7-14 days based on residual erythema alone, as some inflammation persists even after bacterial eradication. 1
When to Add MRSA Coverage
MRSA coverage is NOT routinely necessary for typical nonpurulent cellulitis, even in high-prevalence settings. 1, 2, 3 Add MRSA-active antibiotics ONLY when specific risk factors are present:
MRSA risk factors requiring coverage:
- Penetrating trauma or injection drug use 1, 2
- Purulent drainage or exudate 1, 2
- Evidence of MRSA infection elsewhere or nasal MRSA colonization 1, 2
- Systemic inflammatory response syndrome (SIRS) 1, 2
MRSA-active oral regimens:
- Clindamycin 300-450 mg every 6 hours (monotherapy covering both streptococci and MRSA) 1, 2
- Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily PLUS a beta-lactam 1, 2
- Doxycycline 100 mg twice daily PLUS a beta-lactam 1, 2
Critical caveat: Never use doxycycline or trimethoprim-sulfamethoxazole as monotherapy for typical cellulitis, as their activity against beta-hemolytic streptococci is unreliable. 1, 2
Essential Adjunctive Measures
Beyond antibiotics, these interventions hasten recovery and prevent recurrence:
- Elevate the affected extremity above heart level for at least 30 minutes three times daily to promote gravity drainage of edema 1, 2
- Examine and treat interdigital toe spaces for tinea pedis, fissuring, scaling, or maceration to eradicate colonization 1, 2
- Address predisposing conditions including venous insufficiency, lymphedema, chronic edema, and obesity 1, 2
- Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adults, though evidence is limited 1, 6
When to Escalate Care
Hospitalize immediately if any of the following are present:
- Systemic inflammatory response syndrome (SIRS): fever >38°C, tachycardia >90 bpm, tachypnea >24 rpm 1
- Hypotension or hemodynamic instability 1
- Altered mental status or confusion 1
- Severe immunocompromise or neutropenia 1
- Signs of necrotizing fasciitis: severe pain out of proportion to examination, skin anesthesia, rapid progression, gas in tissue, bullous changes 1
For hospitalized patients with severe cellulitis and systemic toxicity, initiate vancomycin 15-20 mg/kg IV every 8-12 hours PLUS piperacillin-tazobactam 3.375-4.5 g IV every 6 hours for 7-10 days. 1
Prevention of Recurrent Cellulitis
Annual recurrence rates are 8-20% in patients with previous leg cellulitis. 1 For patients with 3-4 episodes per year despite treating predisposing factors, consider prophylactic antibiotics such as:
Duration of prophylaxis ranges from 4-52 weeks depending on risk factors. 2